Authors:
Rimler, A
Culig, Z
Levy-Rimler, G
Lupowitz, Z
Klocker, H
Matzkin, H
Bartsch, G
Zisapel, N
Citation: A. Rimler et al., Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activity, PROSTATE, 49(2), 2001, pp. 145-154
Authors:
Kuniyasu, H
Yasui, W
Pettaway, CA
Yano, S
Oue, N
Tahara, E
Fidler, IJ
Citation: H. Kuniyasu et al., Interferon-alpha prevents selection of doxorubicin-resistant undifferentiated-androgen-insensitive metastatic human prostate cancer cells, PROSTATE, 49(1), 2001, pp. 19-29
Authors:
Jones, HE
Barrow, D
Dutkowski, CM
Goddard, L
Smith, C
Harper, ME
Nicholson, RI
Citation: He. Jones et al., Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: Identification of divergent growth regulatory pathways, PROSTATE, 49(1), 2001, pp. 38-47
Citation: Sc. Li et al., Altered expression of extracellular matrix and proteinases in noble rat prostate gland after long-term treatment with sex steroids, PROSTATE, 49(1), 2001, pp. 58-71
Authors:
Nakamura, T
Mitsui, S
Okui, A
Kominami, K
Nomoto, T
Ukimura, O
Kawauchi, A
Miki, T
Yamaguchi, N
Citation: T. Nakamura et al., Alternative splicing isoforms of hippostasin (PRSS20/KLK11) in prostate cancer cell lines, PROSTATE, 49(1), 2001, pp. 72-78
Authors:
Ravindranath, N
Ioffe, SL
Marshall, GR
Ramaswamy, S
Plant, TM
Dym, M
Citation: N. Ravindranath et al., Androgen depletion activates telomerase in the prostate of the nonhuman primate, Macaca mulatta, PROSTATE, 49(1), 2001, pp. 79-89
Authors:
Burchardt, M
Burchardt, T
Shabsigh, A
Ghafar, M
Chen, MW
Anastasiadis, A
de la Taille, A
Kiss, A
Buttyan, R
Citation: M. Burchardt et al., Reduction of wild type p53 function confers a hormone resistant phenotype on LNCaP prostate cancer cells, PROSTATE, 48(4), 2001, pp. 225-230
Authors:
Iwata, T
Ukimura, O
Inaba, M
Kojima, M
Kumamoto, K
Ozawa, H
Kawata, M
Miki, T
Citation: T. Iwata et al., Immunohistochemical studies on the distribution of nerve fibers in the human prostate with special reference to the anterior fibromuscular stroma, PROSTATE, 48(4), 2001, pp. 242-247
Authors:
Lanzi, C
Cassinelli, G
Cuccuru, G
Supino, R
Zuco, V
Ferlini, C
Scambia, G
Zunino, F
Citation: C. Lanzi et al., Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cells, PROSTATE, 48(4), 2001, pp. 254-264
Authors:
Balaji, KC
Huryk, RF
Verhulst, S
Fair, WR
Citation: Kc. Balaji et al., Growth of heterotopic LNCaP prostate cancer tumor in nude mice is not affected by dietary calcium, PROSTATE, 48(4), 2001, pp. 265-273
Authors:
Sinha, AA
Quast, BJ
Wilson, MJ
Fernandes, ET
Reddy, PK
Ewing, SL
Sloane, BF
Gleason, DF
Citation: Aa. Sinha et al., Ratio of cathepsin B to stefin A identifies heterogeneity within gleason histologic scores for human prostate cancer, PROSTATE, 48(4), 2001, pp. 274-284
Authors:
Bonkhoff, H
Fixemer, T
Hunsicker, I
Remberger, K
Citation: H. Bonkhoff et al., Progesterone receptor expression in human prostate cancer: Correlation with tumor progression, PROSTATE, 48(4), 2001, pp. 285-291
Authors:
Peters, MA
Janer, M
Kolb, S
Jarvik, GP
Ostrander, EA
Stanford, JL
Citation: Ma. Peters et al., Germline mutations in the p73 gene do not predispose to familial prostate-brain cancer, PROSTATE, 48(4), 2001, pp. 292-296
Authors:
Bretland, AJ
Reid, SV
Chapple, CR
Eaton, CL
Citation: Aj. Bretland et al., Role of endogenous transforming growth factor beta (TGF beta) I in prostatic stromal cells, PROSTATE, 48(4), 2001, pp. 297-304
Authors:
Wu, GJ
Varma, VA
Wu, MWH
Wang, SW
Qu, PP
Yang, HC
Petros, JA
Lim, SD
Amin, MB
Citation: Gj. Wu et al., Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues, PROSTATE, 48(4), 2001, pp. 305-315
Authors:
Ilio, KY
Park, II
Pins, MR
Kozlowski, JM
Lee, C
Citation: Ky. Ilio et al., Apoptotic activity of doxazosin on prostate stroma in vitro is mediated through an autocrine expression of TGF-beta 1, PROSTATE, 48(3), 2001, pp. 131-135
Authors:
Shekarriz, B
Upadhyay, J
Bianco, FJ
Tefilli, MV
Tiguert, R
Gheiler, EL
Grignon, DJ
Pontes, JE
Wood, DP
Citation: B. Shekarriz et al., Impact of preoperative serum PSA level from 0 to 10 ng/ml on pathological findings and disease-free survival after radical prostatectomy, PROSTATE, 48(3), 2001, pp. 136-143